Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes.

Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Abstract Text:

    yoshiki ikedaYoshiki Ikeda,hisato takeiHisato Takei,chinami matsumotoChinami Matsumoto,akihito maseAkihito Mase,masahiro yamamotoMasahiro Yamamoto,shuichi takedaShuichi Takeda,atsushi ishigeAtsushi Ishige,kenji watanabeKenji Watanabe,yoshiki ikedaYoshiki Ikeda,hisato takeiHisato Takei,chinami matsumotoChinami Matsumoto,akihito maseAkihito Mase,masahiro yamamotoMasahiro Yamamoto,shuichi takedaShuichi Takeda,atsushi ishigeAtsushi Ishige,kenji watanabeKenji Watanabe,

    Atopic dermatitis can be exacerbated or induced by scratching or psychological stress; both cause the release of substance P (SP) from sensory nerves. Therefore, SP may have an etiological role in mechanisms underlying AD. Here, we show that administration of SP during the primary immune response (PIR) imprinted long-lasting pro-inflammatory immunity, resulting in exacerbation of the secondary immune response (SIR) in the absence of further SP. Five days after sensitization with dinitrofluorobenzene (DNFB), challenge with DNFB together with SP ("SP-Group") resulted in an increased PIR (as evaluated by ear swelling and granulocyte infiltration) compared to DNFB only ("Control-Group"). On day 26, after inflammation completely subsided, a second challenge with DNFB only (without SP) caused an increased SIR in the "SP-Group" compared to controls. Pretreatment on day 5 with spantide, an SP receptor antagonist, prevented increased ear swelling in the "SP-Group" not only on day 5 (PIR) but also on day 26 (SIR). In contrast, spantide treatment on day 26 did not affect the SIR. Adoptive transfer experiments suggested that CD8(+) T cells were involved in mediating enhanced SIR in animals pretreated on day 5 with SP. The present study offers a novel experimental approach to an uninvestigated facet of the pro-inflammatory effect of SP, i.e., exacerbation of inflammation via a long-term and indirect influence on CD8(+) T lymphocytes.

    Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Publishing Authors By Initials

    y ikedaY Ikeda,h takeiH Takei,c matsumotoC Matsumoto,a maseA Mase,m yamamotoM Yamamoto,s takedaS Takeda,a ishigeA Ishige,k watanabeK Watanabe,y ikedaY Ikeda,h takeiH Takei,c matsumotoC Matsumoto,a maseA Mase,m yamamotoM Yamamoto,s takedaS Takeda,a ishigeA Ishige,k watanabeK Watanabe,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Archives of dermatological research

    VOLUME: 299

    Page Numbers: 345-51

    Journal Abbreviation: Arch. Dermatol. Res.

    ISSN: 0340-3696

    DAY: 21

    MONTH: 07

    YEAR: 2007

    Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8000462

    Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes.

    AFFILIATION: Pharmacology Research Department, Central Research Laboratories, Tsumura & Co., Tsumura Research Institute, Yoshiwara 3586, Ami-machi, Inashiki-gun, Ibaraki 300-1192, Japan.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arch Dermatol Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News